Matthew F. Peters

ORCID: 0000-0002-2887-9681
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Muscle Physiology and Disorders
  • Genetic Neurodegenerative Diseases
  • Adipose Tissue and Metabolism
  • Receptor Mechanisms and Signaling
  • Mitochondrial Function and Pathology
  • 3D Printing in Biomedical Research
  • Cardiac electrophysiology and arrhythmias
  • Computational Drug Discovery Methods
  • Photosynthetic Processes and Mechanisms
  • RNA and protein synthesis mechanisms
  • Neuroscience and Neural Engineering
  • Neuropeptides and Animal Physiology
  • Conducting polymers and applications
  • Exercise and Physiological Responses
  • Genomics and Phylogenetic Studies
  • ATP Synthase and ATPases Research
  • Melanoma and MAPK Pathways
  • Pluripotent Stem Cells Research
  • Bacterial Genetics and Biotechnology
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neurogenetic and Muscular Disorders Research
  • Pharmacological Effects and Assays
  • Statistical Methods in Clinical Trials
  • Music Technology and Sound Studies
  • Advanced Biosensing Techniques and Applications

AstraZeneca (United States)
2005-2020

AstraZeneca (Brazil)
2020

AstraZeneca (United Kingdom)
2007-2014

Concordia University
2012-2013

University of Chicago
2012

Wilmington University
2003-2011

University of Washington
2005

Niigata University
2003

Laboratory of Molecular Genetics
2001

Institute of Neurobiology
2001

Expanded polyglutamine repeats have been proposed to cause neuronal degeneration in Huntington's disease (HD) and related disorders, through abnormal interactions with other proteins containing short tracts such as the transcriptional coactivator CREB binding protein, CBP. We found that CBP was depleted from its normal nuclear location present aggregates HD cell culture models, transgenic mice, human postmortem brain. specifically interfere CBP-activated gene transcription, overexpression of...

10.1126/science.1056784 article EN Science 2001-03-23

The syntrophins are a multigene family of intracellular dystrophin-associated proteins comprising three isoforms, α1, β1, and β2. Based on their domain organization association with neuronal nitric oxide synthase, thought to function as modular adapters that recruit signaling the membrane via dystrophin complex. Using sequences derived from new mouse β1-syntrophin cDNA, previously isolated cDNAs for α1- β2-syntrophins, we prepared isoform-specific antibodies study expression, skeletal muscle...

10.1083/jcb.138.1.81 article EN The Journal of Cell Biology 1997-07-14

Huntington's disease is a neurodegenerative disorder resulting from expansion of the polyglutamine region in huntingtin. Although huntingtin normally cytoplasmic, affected brain regions proteolytic fragments mutant containing repeat form intranuclear inclusions. Here, we examine contribution nuclear localization to toxicity by transiently transfecting neuro-2a cells with an N-terminal fragment similar size that believed be present patients. The fragment, HD-N63, was targeted either cytoplasm...

10.1006/mcne.1999.0773 article EN cc-by-nc-nd Molecular and Cellular Neuroscience 1999-08-01

Cardiovascular toxicity, a prominent reason for late-stage failures in drug development, has resulted demand vitro assays that can predict this liability early discovery. Current cardiovascular safety testing primarily focuses on ion channel modulation and low throughput cardiomyocyte (CM) contractility measurements. We evaluated both human induced pluripotent stem cell-derived CMs (hiPSC-CMs) rat neonatal (rat CMs) the xCELLigence Cardio system which uses impedance technology to quantify CM...

10.1093/toxsci/kfu186 article EN Toxicological Sciences 2014-09-18

Becker muscular dystrophy is an X-linked disease due to mutations of the dystrophin gene. We now show that neuronal-type nitric oxide synthase (nNOS), identified enzyme in complex, uniquely absent from skeletal muscle plasma membrane many human patients and mouse models dystrophinopathy. An NH2-terminal domain nNOS directly interacts with alpha 1-syntrophin but not other proteins complex analyzed. However, does associate on sarcolemma transgenic mdx mice expressing truncated proteins. This...

10.1084/jem.184.2.609 article EN The Journal of Experimental Medicine 1996-08-01

Dystrophin-related and -associated proteins are important in the formation maintenance of mammalian neuromuscular junction. We have characterized mouse cDNA clones encoding isoforms dystrophin-homologous 87-kDa postsynaptic protein, dystrobrevin. In Torpedo, protein is multiply phosphorylated closely associated with cytoskeleton, including acetylcholine receptor. contrast to where only a single transcript seen, expresses several mRNAs different isoforms. A 6.0-kilobase brain encodes 78-kDa...

10.1074/jbc.271.13.7802 article EN cc-by Journal of Biological Chemistry 1996-03-01

THE syntrophins are a multigene family of proteins which bind C-terminal domains dystrophin, utrophin and homologs thereof. We report here that antibodies specific for one isoform, β2-syntrophin, labeled only the neuro-muscular junction (NMJ) in rat skeletal muscle. Anti-α1-syntrophin gave strong labeling sarcolemma NMJ normal mouse muscle, similar but much weaker dystrophin-minus mdx β2-Syntrophin therefore appears to be as is utrophin, may involved acetylcholine receptor clustering....

10.1097/00001756-199408150-00009 article EN Neuroreport 1994-08-01

G-protein-coupled receptors can couple to different signal transduction pathways in cell types (termed cell-specific signaling) and activate signaling depending on the receptor conformation(s) stabilized by activating ligand (functional selectivity). These concepts offer potential for developing pathway-specific drugs that increase efficacy reduce side effects. Despite significant interest, functional selectivity has been difficult exploit drug discovery, part due burden of multiple assays....

10.1177/1087057108330115 article EN cc-by-nc-nd SLAS DISCOVERY 2009-02-12

α-Dystrobrevin is both a dystrophin homologue and component of the protein complex. Alternative splicing yields five forms, which two predominate in skeletal muscle: full-length α-dystrobrevin-1 (84 kD), COOH-terminal truncated α-dystrobrevin-2 (65 kD). Using isoform-specific antibodies, we find that localized on sarcolemma at neuromuscular synapse, where, like dystrophin, it most concentrated depths postjunctional folds. α-Dystrobrevin-2 preferentially copurifies with from muscle extracts....

10.1083/jcb.142.5.1269 article EN The Journal of Cell Biology 1998-09-07

Dystrophin, the protein disrupted in Duchenne muscular dystrophy, is one of several related proteins that are key components submembrane cytoskeleton. Three dystrophin-related (utrophin, protein-2 (DRP2), and dystrobrevin) have been described. Here, we identify a human gene on chromosome 2p22-23 encodes novel protein, beta-dystrobrevin, with significant homology to other known dystrobrevin (now termed alpha-dystrobrevin). Sequence alignments including this second strongly support concept two...

10.1074/jbc.272.50.31561 article EN cc-by Journal of Biological Chemistry 1997-12-01

The complete nucleotide sequence of the gene encoding surface (hexagonally packed intermediate [HPI])-layer polypeptide Deinococcus radiodurans Sark was determined and found to encode a 1,036 amino acids. Amino acid analysis about 30% residues revealed that mature consists at least 978 N terminus blocked Edman degradation. results proteolytic modification HPI layer in situ Mr estimations expressed Escherichia coli indicated there is leader sequence. N-terminal region contained very high...

10.1128/jb.169.11.5216-5223.1987 article EN cc-by Journal of Bacteriology 1987-11-01

The diversity and impact of label-free technologies continues to expand in drug discovery. Two classes instruments, using either an electrical impedance-based or optical-based biosensor, are now available for investigating the effects ligands on cellular targets. Studies GPCR function have been especially prominent with these instruments due importance this target class Although both biosensors share similar high sensitivity changes cell shape structure, it is unknown whether yield results...

10.1089/adt.2009.0232 article EN Assay and Drug Development Technologies 2010-01-19

Drug-induced gastrointestinal toxicities (GITs) rank among the most common clinical side effects. Preclinical efforts to reduce incidence are limited by inadequate predictivity of in vitro assays. Recent breakthroughs culture methods support intestinal stem cell maintenance and continual differentiation into epithelial types resident intestine. These diverse cells self-assemble microtissues with vivo-like architecture. Here, we evaluate human GI grown transwell plates that allow apical...

10.1093/toxsci/kfy268 article EN cc-by-nc Toxicological Sciences 2018-10-25

Huntington's disease is caused by an expanded CAG trinucleotide repeat coding for a polyglutamine stretch within the huntingtin protein. Currently, function of normal and mechanism which causes selective neurotoxicity remain unknown. Clues may come from identification huntingtin-associated proteins (HAPs). Here, we show that copurifies with single novel 40-kDa protein termed HAP40. HAP40 encoded open reading frame factor VIII-associated gene A (F8A) located intron 22 VIII gene. In...

10.1074/jbc.m008099200 article EN cc-by Journal of Biological Chemistry 2001-02-01

Cellular dielectric spectroscopy (CDS) is an emerging technology capable of detecting a range whole-cell responses in label-free manner. A new CDS-based instrument, CellKey, has been developed that optimized for G-protein coupled receptor (GPCR) detection and automated liquid handling microplate format, thereby making CDS accessible to lead generation/optimization drug discovery. In addition having sufficient throughput, assay technologies must pass rigorous standards development, signal...

10.1177/1087057106298637 article EN cc-by-nc-nd SLAS DISCOVERY 2007-02-17

Drug-induced gastrointestinal toxicity (GIT) is a common treatment-emergent adverse event that can negatively impact dosing, thereby limiting efficacy and treatment options for patients. An in vitro assay of GIT needed to address patient variability, mimic the microphysiology gut, accurately predict drug-induced GIT. Primary human ileal organoids (termed 'enteroids') have proven useful stimulating intestinal stem cell proliferation differentiation multiple types present gut epithelium....

10.1016/j.tiv.2020.104928 article EN cc-by-nc-nd Toxicology in Vitro 2020-07-03
Coming Soon ...